EW vs UTL · P/E 47, rev $1.39B vs P/E 16, rev $494.8M
Edwards Lifesciences Corp (EW) versus UNITIL Corporation (UTL) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
UNITIL Corporation (UTL) is a utilities - diversified company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported UTL revenue for 2024-12-31 was $494.8M. Net income was $47.1M. Revenue was down 11.2% from 2023-12-31 to 2024-12-31. UTL currently screens at market cap $921.7M and trailing P/E 16.4.
EW currently screens at market cap $49.91B and trailing P/E 46.9. UTL currently screens at market cap $921.7M and trailing P/E 16.4.
Not investment advice. Open the EW and UTL stock pages for the full models.
Not investment advice.